Feedback / Questions
KER-0193 - Kaerus Bioscience
https://www.pharmiweb.com/pwtoday-story/kaerus-bioscience-s-lead-candidate-ker-0193-granted-orphan-drug-designation-and-rare-pediatric-drug-designation-by-us-fda-for-treatment-of-fragile-x-syndrome-fxs
 
May 14, 2025
 
SHARE THIS
  • Print
  • Email
  • More sharing
    Reddit
    StumbleUpon
    Delicious